Rameda Pharmaceuticals: Covid-related antivirals support sales growth but pressure margins
Retail market continues to slowly recover in 1Q21
New launches’ sales and covid related antivirals drive topline growth
Higher covid-related antivirals’ initial APIs costs pressure operating margins
Associate @ Al Ahly Pharos Securities Brokerage
